Plethico Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 March 2016, to consider, approve and take on record the audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31 March 2015.

Powered by Capital Market - Live News

Plethico Pharmaceuticals announced that the Board of Directors vide its resolution dated 05 February 2016 have approved the following:

1. Appointment of Milindkumar Laxmishankar Dixit as an Independent Director (Additional Director) on the Board of the Company for a period of five years with effect from 05 February 2016 subject to approval of the members at the ensuing General Meeting.

2. Acceptance of Resignation given by Chirag Patel as Whole time director of the Company. Chirag Patel has resigned with effect from 05 February 2016 from the position of Whole Time Director of the Company.

3. Adoption of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) including authorizing Shashikant Patel, Chairman and Managing Director of the Company to enter into amended Listing Agreement and submission of the same to BSE and any other applicable authorities, if required.

4. The re-constitution of Committees.

5. As per section 178 of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Remuneration Committee has been renamed with Nomination and remuneration Committee w.e.f. 05 February 2016.

Powered by Capital Market - Live News

Plethico Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 29 December 2015 Fixing December 29, 2015, for holding Extra Ordinary General Meeting of the members of the Company at the Registered Office of the Company for the appointment of auditor in casual vacancy.

Powered by Capital Market - Live News

Plethico Pharmaceuticals announced the following -

1. Acquisition of Natrol inc, USA by Aurobindo Pharma:-

In continuation to our earlier communication regarding Acquisition of Natrol Inc., a step down subsidiary of the Company it is updated that the said acquisition transaction took place under an auction deal held on 10 November 2014 as per the direction of the United States Bankruptcy Court for the District of Delaware and the highest bidder was Aurobindo Pharma who has been awarded the bid by the said court.

The said acquisition transaction is likely to be completed shortly under the direction of the said court, the Intimation of which shall be communicated in due course.

2. Merging of Administrative Office of the Company with the Registered Office of the Company:-

The Company has vacated the Administrative Office premises taken on lease situated at 37, Industrial Estate, PoIoground. Indore 452015 (M.P) therefore administrative office has now been merged with the Registered Office of the Company situated at A B. Road, Manglia-453773, Indore (M.P.). Henceforth all the statutory records, Books of Accounts, etc. will be kept by the Company at the registered office of the Company.

3. Resignation of Company Secretary:-

Khushboo Kothari, Company Secretary, ceased to be the Company Secretary and subsequently Compliance Officer of the Company, w.e.f. 25 May 2015, and consequent to his resignation dated 06 February 2015. In the absence of Company Secretary, Shashikant Patel, Managing Director of the Company will be the Compliance officer of the Company.

Powered by Capital Market - Live News